Skip to main content

Ikarian Capital, LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1778253 DALLAS, TX

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,456,378
-8.8% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$0
PutShares
1,200,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,456,378
2026-03-31 1,200,000
2025-12-31 1,596,378
2025-09-30 164,202
2025-06-30 58,491
2025-03-31 308,491
2024-12-31 308,491
2024-09-30 308,497
2024-06-30 458,497
2024-03-31 88,497
2023-12-31 165,480
2023-09-30 165,480
2023-09-30 2,000
2023-06-30 315,480
2023-06-30 200,000
2023-03-31 721,341
2022-12-31 737,319
2022-09-30 904,119
2022-06-30 700,000